Choi Kyung Suk, Lee Eunsook, Rhie Sandy Jeong
Division of Life and Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.
Department of Pharmacy, Seoul National University Bundang Hospital, Seoungnam-si, Republic of Korea.
Int J Clin Pharm. 2019 Apr;41(2):424-433. doi: 10.1007/s11096-019-00796-5. Epub 2019 Mar 12.
Background Early interventions with clinical decision support system (CDSS) guidance have ensured appropriate drug dosing for patients with renal impairment. However, the low rates of physician compliance with CDSS alerts have been reported. Objective We investigated whether designated pharmacist interventions were associated with physician' acceptance of the knowledge-based renal dosage adjustment system (K-RDS) for patients with reduced renal function. Setting A retrospective, single-center study was conducted using a healthcare information system at a tertiary teaching hospital. Methods This study compared physicians' acceptance of the K-RDS with and without designated pharmacists. The severity of prescription errors and the impact of service provided by the pharmacist were evaluated using the validated method developed by Overhage and Lukes. From April to June 2017, we enrolled patients who were ≥ 20 years of age and admitted with an estimated glomerular filtration rate under 50 ml/min on medications that required dose adjustments. Main outcomes measure The number of dosing alerts of the K-RDS and physicians' acceptance rates were compared between a control group guided by the central pharmacy only and a group with assigned designated pharmacists. The factors associated with the physicians' acceptance rate were also analyzed using a multivariate logistic regression method. The impact of service provided by the pharmacist were considered as 'highly significant' (categories: 1-2). Severity of prescription errors were defined as 'serious' if they corresponded to categories 1-2 of the Overhage and Lukes scale for severity, and interventions were relevant if they corresponded to categories 1-3 in the impact of service provided by the pharmacist scale. Results Among 1363 prescription interventions, 491 (36.0%) were performed by designated pharmacists. The K-RDS alert acceptance rate by the physicians was 54.4% in the designated pharmacist group and 47.0% in the control group (p = 0.0233). The statistically significant association was found in the designated pharmacists group in 'highly significant' service provided by the pharmacist (p < 0.001, OR 1.772; 95% CI 1.362-2.305) and 'serious' severity of prescription errors (p = 0.012, OR 1.657; 95% CI 1.116-2.460). The presence of designated pharmacists (OR 1.353, p = 0.0272), patient's gender (OR 0.758, p = 0.0016), department specialty (OR 0.659, p < 0.0001), eGFR (OR 1.538 if < 10 ml/min; OR 1.519 if 10-40 ml/min, p < 0.0001), and medications (OR 6.058-43.992 depending on the medication category, p < 0.0001) were significant factors affecting physicians' acceptance. Conclusion Pharmacists' interventions effectively improved physicians' acceptance of the K-RDS alerts.
早期在临床决策支持系统(CDSS)指导下进行的干预措施已确保为肾功能不全患者合理用药。然而,有报道称医生对CDSS警报的依从率较低。目的:我们调查了指定药剂师的干预措施是否与医生对基于知识的肾功能减退患者剂量调整系统(K-RDS)的接受度相关。设置:在一家三级教学医院使用医疗信息系统进行了一项回顾性单中心研究。方法:本研究比较了有和没有指定药剂师时医生对K-RDS的接受情况。使用Overhage和Lukes开发的经过验证的方法评估处方错误的严重程度以及药剂师提供的服务的影响。2017年4月至6月,我们纳入了年龄≥20岁、因估计肾小球滤过率低于50 ml/min而入院且正在使用需要调整剂量药物的患者。主要结局指标:比较仅由中心药房指导的对照组和有指定药剂师的组之间K-RDS的给药警报数量和医生的接受率。还使用多因素逻辑回归方法分析与医生接受率相关的因素。药剂师提供的服务的影响被视为“高度显著”(类别:1 - 2)。如果处方错误对应于Overhage和Lukes严重程度量表的1 - 2类,则定义为“严重”,如果干预对应于药剂师提供的服务影响量表中的1 - 3类,则认为干预是相关的。结果:在1363次处方干预中,491次(36.0%)由指定药剂师进行。指定药剂师组中医生对K-RDS警报的接受率为54.4%,对照组为47.0%(p = 0.0233)。在药剂师提供“高度显著”服务的指定药剂师组中发现了统计学上的显著关联(p < 0.001,OR 1.772;95% CI 1.362 - 2.305)以及处方错误“严重”的情况(p = 0.012,OR 1.657;95% CI 1.116 - 2.460)。指定药剂师的存在(OR 1.353,p = 0.0272)、患者性别(OR 0.758,p = 0.0016)、科室专业(OR 0.659,p < 0.0001)、估算肾小球滤过率(如果<10 ml/min,OR 1.538;如果10 - 40 ml/min,OR 1.519,p < 0.0001)以及药物(根据药物类别,OR 6.058 - 43.992,p < 0.0001)是影响医生接受度的显著因素。结论:药剂师的干预有效地提高了医生对K-RDS警报的接受度。